Atherosclerosis in ApoE-deficient Mice Progresses Independently of the NLRP3 Inflammasome

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2011.18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Deficiency of PXR Decreases Atherosclerosis in apoE-deficient Mice

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2011English

Comment on “Deficient NLRP3 and AIM2 Inflammasome Function in Autoimmune NZB Mice”

Journal of Immunology
AllergyImmunology
2015English

Porphyromonas Gingivalis Accelerates Inflammatory Atherosclerosis in the Innominate Artery of ApoE Deficient Mice

Atherosclerosis
Cardiovascular MedicineCardiology
2011English

The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
1999English

Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2002English

Role of NLRP3 Inflammasome in Atherosclerosis and Aortic Aneurysm

The Journal of Japanese College of Angiology
2019English

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice

Mediators of Inflammation
ImmunologyCell Biology
2014English

Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Fenretinide Treatment Accelerates Atherosclerosis Development in apoE‐deficient Mice in Spite of Beneficial Metabolic Effects

British Journal of Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy